Denmark declines to reimburse semaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
The archive — 2024
Page 43 of 68 of this archive, newest first.
Hong Kong export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Why a dead-clean sterile filter can pass pyrogen straight through
The masking phenomenon known as low endotoxin recovery means a formulation can return a clean result while containing endotoxin the assay cannot see.
The effect profile, predicted from an expression map
The receptor populations that produce satiety and the ones that produce nausea overlap substantially. That is why the ceiling of this drug class is where it is, and it is…
PeptideMeter result on a Guangzhou orforglipron lot lands 3.3 points below the supplier’s figure
A reminder that a purity figure is the output of a method, and that methods differ.
Turkey caps semaglutide prescribing to 17 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
What changed at HJ in May, and what the company will not say about it
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
What the new Germany guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
What we would need to randomise to answer this properly
One randomised trial has combined a GLP-1 receptor agonist with supervised exercise. Its result is the single most useful piece of evidence in this area.
Why people actually stop, in the order they actually stop
A supply interruption is a discontinuation with no notice, no taper and no plan. That is a distinct clinical situation.
The badge economy, and what it is actually certifying
What a verification mark would have to carry to be checkable: a date, a lot, a method, a submitter and a link to the report.
Portugal health authority warns on falsified liraglutide pens
Reported from the analysis, not from a warning notice.
The quiet end of the relabeller trading as Vantris Bio
A proper account of an operation that existed, and of what closing it cost.
A shortage listing ends. 10 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
TRIUMPH-3 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
What a laboratory knows about the material it receives
Chain of custody, in a regulated setting, begins at sampling. Here it begins when the package arrives.
The consolidator trading as Meridian Freight Partners closes after 7 years
A proper account of an operation that existed, and of what closing it cost.
The 13-day notice: how a compounding wind-down works in France
The document is four pages. Three of them are about dates.
SURMOUNT-OSA misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
What twenty companies say about storage, and what they have measured
A stability programme needs a protocol, defined conditions, a stability-indicating method and time. Time is the ingredient no commercial testing service can sell.
Side effects, cost, supply, target: four reasons with four trajectories
Why the reason for stopping changes what happens afterwards.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
Inspectors cite the online reseller trading as Adamant Research Supply over sterility assurance
The observation that closes a facility is rarely the dramatic one.
What a 38% rise in coupling-reagent prices does to a 15 mg vial
Follow the resin, not the catalogue.
Turkey caps liraglutide prescribing to 8 specialist centres
Efficacy was never the question in this appraisal. Duration of treatment was.
Who signed this, and what did they undertake by signing it
Two signatures — one who performed the work, one who approved its release — are the ordinary regulated convention and are almost unknown here.
Gastric emptying is a mechanism, not a side effect
The central effects are not a bonus. On the current evidence they are the principal mechanism of weight loss.
A supplier suspends shipping to Mexico after 12 consecutive customs detentions
The route did not close because of a rule about peptides.
The slide that was not in the abstract
Reported from the sessions, and from the two hours afterwards.
New Zealand declines to reimburse dulaglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.